Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.